# Cefuroxime sodium

NDC: 25021-119
Generic name: Cefuroxime sodium
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20160901

FDA application: ANDA064125

## Active ingredients

- CEFUROXIME SODIUM: 1.5 g/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-119"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-119
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a145288-733a-4966-b7ae-dc96eb103d8c